Shimin Hu

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

Shimin Hu, Zijun Y. Xu‐Monette, Alexandar Tzankov et al. · Blood · 2013 · 679 citations · Full text

Medicine, Cancer Biology, Oncology +15

I-FLICE, a Novel Inhibitor of Tumor Necrosis Factor Receptor-1- and CD-95-induced Apoptosis

Shimin Hu, Claudius Vincenz, Jian Ni et al. · Journal of Biological Chemistry · 1997 · 378 citations · Full text

Life Sciences, Cell Biology, Immunology +16

TIPE2, a Negative Regulator of Innate and Adaptive Immunity that Maintains Immune Homeostasis

Honghong Sun, Shunyou Gong, Ruaidhrı́ J. Carmody et al. · Cell · 2008 · 372 citations · Full text

Life Sciences, Immunology, Molecular Genetics +16

A Novel Family of Viral Death Effector Domain-containing Molecules That Inhibit Both CD-95- and Tumor Necrosis Factor Receptor-1-induced Apoptosis

Shimin Hu, Claudius Vincenz, Mark Buller et al. · Journal of Biological Chemistry · 1997 · 343 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Altered Expression of Retinoblastoma Protein and Known Prognostic Variables in Locally Advanced Bladder Cancer

C. Logothetis, Hang Xu, J Y Ro et al. · JNCI Journal of the National Cancer Institute · 1992 · 252 citations

Medicine, Oncology, Pathology +17